$LAZ

Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital

Lazard Inc. (NYSE: LAZ) completed its acquisition of Campbell Lutyens, launching Lazard CL, a global leader in private capital advisory. The deal, announced in April 2026, combines Lazard's and Campbell Lutyens' operations, creating a platform with 300 professionals and 19 offices worldwide. Lazard CL is expected to generate $500 million in revenue in 2027 and be accretive to earnings, according to the company.

Original reporting
Published Nov 2, 2026, 6:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 6:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital — source image
Decision brief

The 30-second read

$LAZBullishMed
01

Why it matters

The acquisition is positioned as a strategic expansion that should be earnings‑accretive and diversify revenue streams.

02

Market read

First report of the deal's completion with forward‑looking revenue and earnings impact, relevant for equity traders and M&A analysts.

03

What to watch

Potential cultural integration challenges and the lock‑up period could delay realized synergies.

Relevance 8/10Novelty 8/10Timing: immediate

Background

Press release from Lazard detailing the finalization of its acquisition of Campbell Lutyens and the creation of Lazard CL.

Company-level read

Ticker impact

$LAZBullishHigh confidence
Context

Lazard announced completion of its acquisition of Campbell Lutyens and launch of Lazard CL, projecting $500M revenue and earnings accretion in 2027.

Expected impact

likely upward pressure as investors price in earnings accretion

Evidence & confidence

The deal is completed, revenue guidance is disclosed, and the market typically rewards accretive acquisitions of this scale.

Market effects

Strengthens the private capital advisory niche and may spur consolidation in boutique advisory firms.

Boosts Lazard's presence in North America, Europe, Middle East and Asia-Pacific.

Adds a major player to the global private capital advisory landscape.

Counterpoint

Some investors may view the integration risk and dilution from stock‑based consideration as a downside.

Key entities

  • Lazard Inc.

    Global financial advisory firm completing the acquisition.

  • Campbell Lutyens

    Private capital advisory firm being acquired.

Related articles

HighAI 9/10

Lazard Says Campbell Lutyens Deal Closed, Launches Advisory Unit

Lazard completed its $460M acquisition of Campbell Lutyens, launching Lazard CL. The new unit will advise on private capital markets, with over 300 professionals. Lazard expects the deal to boost revenue and earnings, targeting $500M combined revenue in 2027. The acquisition aligns with Lazard's 2030 strategy to diversify services.

$LAZHighAI 8/10

Lazard completes Campbell Lutyens acquisition, launches new unit

Lazard Inc. (NYSE:LAZ) completed its acquisition of Campbell Lutyens, launching Lazard CL, a private capital advisory unit. The deal, paid mostly in Lazard stock, combines their advisory operations. Lazard CL has 300+ professionals across 19 offices and has advised on over $1 trillion in capital. The company expects Lazard CL to generate $500M in revenue in 2027, boosting earnings.

$LAZMed

The firms behind Lazard's new business advised on more than $1 trillion in fundraising and investment resales over four decades.

Lazard, Inc. (NYSE: LAZ) launched Lazard CL, a new global business combining its advisory services with those of Campbell Lutyens. The firm aims to strengthen its private capital advisory capabilities, offering a range of services across private equity, credit, infrastructure, and real estate. Lazard paid primarily in stock for the acquisition, which is performing ahead of expectations. The deal is expected to enhance Lazard's global reach and revenue.

$BWXTMed

Not Oklo. Not NuScale. The Army Picked This Nuclear Stock to Power Fort Campbell.

BWX Technologies (BWXT) was chosen by the U.S. Army to develop a 20-megawatt nuclear microreactor at Fort Campbell, Kentucky, as part of a $2.2 billion program. BWXT's selection outpaces competitors like Oklo and NuScale, leveraging its established nuclear business and existing contracts. The reactor is expected to begin operations in the early 2030s, with BWXT reporting $902 million in Q2 2026 revenue and an $8.4 billion backlog.